Logo Image
|Articles|April 4, 2016

Building Regulatory Capacity: MRCT Workshop in Singapore

Author(s)DIA

With the globalization of the pharmaceutical industry, multiregional clinical trials (MRCTs) have steadily increased over the past decade. In March 2016, the Centre of Regulatory Excellence (CoRE), Duke-NUS Medical School Singapore – recently designated as an APEC Center of Excellence (CoE) for regulatory training in MRCTs – organized and hosted the second APEC CoE MRCT Workshop in Singapore, following the successful pilot Workshop in Singapore in 2014.

Read more here.

Related to this article

View more
Pharmaceutical Executive Daily
Pharmaceutical Executive Daily: FDA Approves Tecentriq
The FDA approves Roche’s Tecentriq for a subset of colon cancer patients, TRexBio and Retension Pharmaceuticals price new IPOs, and a Pharmaceutical Executive feature examines what it takes to turn precision medicine’s biological gains into deliverable therapies.
Read more
Naoki Okamura: Post-Patent Plan and Purpose
Naoki Okamura: Post-Patent Plan and Purpose
Astellas CEO Naoki Okamura is putting a “patient axis” operating model, a broader portfolio of strategic brands and a new generation of science to work in the company’s bid to return to record growth.
Read more